Think Bioscience Funding: $98M Raised, Series A (2026)
Think Bioscience is a Biotech company based in Boulder. It has raised $98M in total funding. Latest round: Series A.
Think Bioscience funding overview
Think Bioscience is a Biotech company based in Boulder. Think Bioscience has raised $98M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2026. The round record for Think Bioscience runs through 2026; nothing later has been disclosed. Investors on record include Innovation Endeavors, Regeneron Ventures, Janus Henderson Investors, YK Bioventures, AV8 Ventures. 5 distinct backers are named across the disclosed rounds.
Think Bioscience has raised $98M in total disclosed funding across the rounds on record.
Who has invested in Think Bioscience?
Innovation Endeavors, Regeneron Ventures, Janus Henderson Investors, YK Bioventures, AV8 Ventures are named among the investors backing Think Bioscience.
What was the latest Think Bioscience funding round?
The most recent disclosed round is a Series A, announced in January 2026.
Where is Think Bioscience based?
Think Bioscience is based in Boulder.
What sector does Think Bioscience operate in?
Think Bioscience is tracked under Biotech from Boulder, with $98M in disclosed funding.
When did Think Bioscience last raise?
The last disclosed Think Bioscience round closed in January 2026 at Series A.
Totals shown for Think Bioscience aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boulder and the investors behind them below.
